late-stage clinical trial - International Biopharmaceutical Industry

Current Edition

news

Rebounding from setbacks, Sanofi reveals promising data for hemophilia drug

An experimental hemophilia drug cut bleeding episodes by 90% in patients who took it when compared to those given standard treatments in a late-stage clinical trial, ...

15 December 2021 news data | hemophilia B

Continue Reading →

news

Sarepta embarks on late-stage clinical trial of Duchenne gene therapy

Although Pfizer beat Sarepta to start a Phase 3 trial of its gene therapy, the smaller biotech is claiming a milestone in initiating the study in the U.S. as well as ...

8 October 2021 news Biotech | Duchenne

Continue Reading →

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Current Edition

Upcoming Events

Advertisement

Rebounding from setbacks, Sanofi reveals promising data for hemophilia drug

Sarepta embarks on late-stage clinical trial of Duchenne gene therapy

International Biopharmaceutical Industry